Home > Financial Ratios > GENNEX LABORATORIES

GENNEX LABORATORIES
Core EBITDA Growth

    Back to All Ratios
GENNEX LABORATORIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENNEX LABORATORIES
Please provide your vote to see the results

GENNEX LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 23.75153.7027.91-4.2368.10

What is the latest Core EBITDA Growth ratio of GENNEX LABORATORIES ?

The latest Core EBITDA Growth ratio of GENNEX LABORATORIES is 23.75 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202523.75
Mar2024153.70
Mar202327.91
Mar2022-4.23
Mar202168.10

How is Core EBITDA Growth of GENNEX LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 23.75
-84.55
Mar2024 153.7
450.70
Mar2023 27.91
Positive
Mar2022 -4.23
Negative
Mar2021 68.1 -

Other Financial Ratios of GENNEX LABORATORIES


Compare Core EBITDA Growth ratio of peers of GENNEX LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENNEX LABORATORIES ₹215.9 Cr -0.1% -8.8% -28.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹465,471.0 Cr -0.5% 0.8% 19% Stock Analytics
DIVIS LABORATORIES ₹226,631.0 Cr 2.2% 23.1% 27.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,157.0 Cr -2.6% -1.6% 36% Stock Analytics
CIPLA ₹118,108.0 Cr 0.8% 2.5% -3.7% Stock Analytics
DR REDDYS LABORATORIES ₹100,578.0 Cr 2.6% -2.4% -5.6% Stock Analytics


GENNEX LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENNEX LABORATORIES

-0.1%

-8.8%

-28.8%

SENSEX

-0.4%

0.8%

-3%


You may also like the below Video Courses